Bronstein, Gewirtz & Grossman, LLC Is Investigating Phathom Pharmaceuticals, Inc. (PHAT) And Encourages Shareholders to Connect
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Phathom Pharmaceuticals, Inc. (PHAT) after the company lowered its full-year 2026 net revenue guidance, contradicting earlier affirmations. The investigation focuses on whether the company made misleading statements to investors regarding its financial outlook and …